Self-Recognition of Cd1 by γ/δ T Cells: Implications for Innate Immunity by Spada, Franca M. et al.
 
937
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/2000/03/937/12 $5.00
Volume 191, Number 6, March 20, 2000 937–948
Released online 13 March 2000
http://www.jem.org/cgi/current/full/191/6/937
 
Self-Recognition of CD1 by 
 
g
 
/
 
d
 
 T Cells:
Implications for Innate Immunity
 
By Franca M. Spada,
 
*
 
 Ethan P. Grant,
 
*
 
 Peter J. Peters,
 
‡
 
Masahiko Sugita,
 
*
 
 Augustín Melián,
 
*
 
 David S. Leslie,
 
*
 
 
 
Hoi K. Lee,
 
§ 
 
Elly van Donselaar,
 
‡
 
 Dennis A. Hanson,
 
i
 
 
Alan M. Krensky,
 
¶ 
 
Otto Majdic,
 
**
 
 Steven A. Porcelli,
 
*
 
 
Craig T. Morita,
 
§
 
 and Michael B. Brenner
 
*
 
From the 
 
*
 
Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Brigham 
 
and Women’s Hospital at Harvard Medical School, Boston, Massachusetts 02115; 
 
‡
 
The Netherlands 
Cancer Institute, 1066 CX Amsterdam, The Netherlands; the 
 
§
 
Division of Rheumatology, 
Department of Internal Medicine and Interdisciplinary Graduate Program in Immunology, University 
 
of Iowa, Iowa City, Iowa 52242; the 
 
i
 
Virginia Mason Research Center, Seattle, Washington 98101; 
the 
 
¶
 
Division of Immunology and Transplantation Biology, Department of Pediatrics, Stanford 
University, Stanford, California 94305; and the 
 
**
 
Institute of Immunology, University of Vienna, 
A-1090 Vienna, Austria
 
Abstract
 
The specificity of immunoglobulins and 
 
a
 
/
 
b
 
 T cell receptors (TCRs) provides a framework
for the molecular basis of antigen recognition. Yet, evolution has preserved a separate lineage
of 
 
g
 
/
 
d
 
 antigen receptors that share characteristics of both immunoglobulins and 
 
a
 
/
 
b
 
 TCRs but
whose antigens remain poorly understood. We now show that T cells of the major tissue 
 
g
 
/
 
d
 
 T
cell subset recognize nonpolymorphic CD1c molecules. These T cells proliferated in response
 
to CD1
 
1
 
 presenter cells, lysed CD1c
 
1
 
 targets, and released T helper type 1 (Th1) cytokines.
The CD1c-reactive 
 
g
 
/
 
d
 
 T cells were cytotoxic and used both perforin- and Fas-mediated cy-
totoxicity. Moreover, they produced granulysin, an important antimicrobial protein. Recogni-
tion of CD1c was TCR mediated, as recognition was transferred by transfection of the 
 
g
 
/
 
d
 
TCR. Importantly, all CD1c-reactive 
 
g
 
/
 
d
 
 T cells express V
 
d
 
1 TCRs, the TCR expressed by
most tissue 
 
g
 
/
 
d
 
 T cells. Recognition by this tissue pool of 
 
g
 
/
 
d
 
 T cells provides the human im-
mune system with the capacity to respond rapidly to nonpolymorphic molecules on profes-
sional antigen presenting cells (APCs) in the absence of foreign antigens that may activate or
eliminate the APCs. The presence of bactericidal granulysin suggests these cells may directly
mediate host defense even before foreign antigen-specific T cells have differentiated.
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Introduction
 
Studies in mice and humans have implicated 
 
g
 
/
 
d
 
 T cells in
host defense. For example, 
 
g
 
/
 
d
 
 T cells modulate the sever-
ity of disease or mediate a component of protective immu-
nity in murine models of listeriosis (1), tuberculosis (2–4),
malaria (5), and HSV-1 encephalitis (6). 
 
g
 
/
 
d
 
 T cells are
critically important in preventing death from airway infec-
 
tion with 
 
Nocardia asteroides
 
 (7). In humans, large expan-
sions of 
 
g
 
/
 
d
 
 T cells during infections suggest their impor-
tance. 
 
g
 
/
 
d
 
 T cells increase from normal levels of 4% of all
circulating T cells to a mean of 12, 14, 29, and 57% of all
 
circulating T cells during infection with 
 
Listeria monocytog-
 
enes
 
, 
 
Mycobacterium tuberculosis
 
, 
 
Brucella melitensis
 
, and 
 
Ehr-
lichia chaffeensis
 
, respectively (8–11). Despite the growing
list of experimental models and human diseases with 
 
g
 
/
 
d
 
 T
cell expansions, only a few examples of well-characterized
antigen-specific 
 
g
 
/
 
d
 
 T cells have been noted, and these do
not support MHC-restricted peptide-specific recognition
(12, 13). Instead, in mice, 
 
g
 
/
 
d
 
 T cell recognition of an in-
tact (unprocessed) cell surface glycoprotein of HSV was
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Human CD1c-reactive 
 
g
 
/
 
d
 
 T Lymphocytes
 
noted in one case, whereas in other cases, alloreactive 
 
g
 
/
 
d
 
T cell recognition of TL and I-E was not dependent on
bound peptides (14–16). These studies, together with anal-
ysis of CDR3 length distribution of the TCR 
 
d
 
 chain (17)
and the structure of a V
 
d
 
 domain revealing shared features
with both immunoglobulins and 
 
a
 
/
 
b
 
 TCRs (18), led to
the suggestion that, in some cases, 
 
g
 
/
 
d
 
 recognition may be
more like that of immunoglobulins than of 
 
a
 
/
 
b
 
 TCRs.
Major advances in the study of antigen recognition by
human 
 
g
 
/
 
d
 
 T cells were made with the discovery that most
circulating human 
 
g
 
/
 
d
 
 T cells that bear V
 
g
 
2/V
 
d
 
2 (V
 
g
 
2 is
also termed V
 
g
 
9) TCRs could be stimulated
 
 
 
by nonpeptide
antigens (for a review, see reference 19) derived from 
 
My-
cobacteria
 
 (20–24). These nonpeptide antigens were identi-
fied as isopentenyl pyrophosphate (IPP)
 
1
 
 and related prenyl
pyrophosphate molecules (24, 25) and the more recently
characterized alkylamine antigens (26). Both the phosphate
and the amine antigens are small molecules consisting of
short (typically one to five carbons) straight or branched al-
iphatic chains and either a phosphate or an amine moiety.
They are important products of microbes as well as self-
antigens. The mechanism by which these antigens are pre-
sented is not known, but it does not involve the known
MHC class I or MHC class II peptide antigen-presenting
molecules (23, 27, 28), and we have suggested they may be
recognized much as haptens are recognized by either im-
munoglobulins or TCRs (23, 29). Namely, their require-
ment for an antigen-presenting element is unclear, but
their recognition is critically dependent on the CDR3 se-
quence of the 
 
g
 
/
 
d
 
 TCR (29, 30). The recognition of these
small aliphatic phosphate and amine organic molecules was
exclusively found among 
 
g
 
/
 
d
 
 T cells of the V
 
d
 
2 subset.
In contrast to V
 
g
 
2/V
 
d
 
2
 
1
 
 T cells that are the major cir-
culating pool of 
 
g
 
/
 
d
 
 T cells, human 
 
g
 
/
 
d
 
 T cells bearing
V
 
d
 
1-encoded TCRs account for the vast majority of 
 
g
 
/d T
cells in tissues such as intestine and spleen (31). Yet, little is
known about the antigen reactivity of these tissue g/d T
cells. Recently, examples of g/d T cells in this subset were
found to recognize the MHC-encoded proteins, MICA
and MICB (32). Recognition was through the activating
NKG2D C-type lectin (33) with an unclear contribution
from the g/d TCR. MICA and MICB class I molecules
identify stressed cells and have a very restricted pattern of
expression primarily limited to the intestine. MICA and
MICB probably do not present peptides, as they have a
limited peptide binding groove (34). Instead, these mole-
cules may function in innate immunity as important targets
for Vd11 g/d T cell killing of stressed cells (32).
Here, we provide evidence that an important TCR-
mediated reactivity of tissue g/d T cells is against CD1
molecules. Remarkably, all of the Vd1 cells studied were
focused specifically on CD1c, one member of a family of
nonpolymorphic CD1 molecules, expressed exclusively on
APCs, that present lipid and glycolipid foreign antigens to
T cells (35). However, the g/d T cell lines and clones
showed highly specific, direct reactivity to CD1c proteins
that was not dependent on the presence of an exogenous
foreign antigen. These CD1c-specific g/d T cells produced
inflammatory cytokines, killed CD1c-bearing targets, and
contained bactericidal granulysin.
Materials and Methods
mAbs. The following mAbs were used for flow cytometry
and blocking experiments: P3 (IgG control) (22), SPV-T3b (anti-
CD3) (36), anti–TCR-d1 (pan anti-Cd) (37), dTCS1 (anti-Vd1/
Jd1) (38), TigA (anti-Vg2) (39, 40), 9.3 (anti-CD28) (41), OKT4
(anti-CD4; American Type Culture Collection), OKT8 (anti-
CD8a; American Type Culture Collection), DX1 (anti–NKR-
P1A; provided by Dr. L. Lanier, DNAX, Palo Alto, CA), BMAO31
(pan anti–TCR-a/b; provided by Dr. R.G. Kurrle, Boehring-
werke, Marburg, Germany), 7C6 (anti-CD1c) (42), F10/21A3
(anti-CD1c) (42a), BCD1b3.2 (anti-CD1b) (43), 10H3.9.3 (anti-
CD1a) (44), W6/32 (anti–MHC class I; American Type Culture
Collection), L243 (anti–HLA-DR; American Type Culture Col-
lection), NS4.1 (IgM control; American Type Culture Collection),
4A11 (anti-Vg1.4) (45), CD95 Fas ZB4 clone (anti-Fas; Immuno-
tech), dG9 (antiperforin; Ancell), DH2 (antigranulysin) (46), and
MPC11 (IgG2b control; American Type Culture Collection).
Immunofluorescence Analysis. Cells were incubated with mouse
mAbs on ice for 30 min, washed, and stained with FITC-conju-
gated F(ab9)2 goat anti–mouse Ig (Tago) for an additional 30 min
on ice. After washing, the cells were resuspended in propidium
iodide and analyzed by flow cytometry (FACSort™; Becton
Dickinson). Results were expressed as percentage of positive cells
compared with negative cells stained with isotype-matched con-
trol mAbs.
T Cell Lines and Clones. Lymphocytes were isolated from the
blood of random healthy donors by Ficoll-Hypaque centrifuga-
tion. g/d T cells were enriched by staining with the anti–TCR-
a/b mAb, BMAO31, followed by depletion of a/b T cells with
magnetic beads coated with goat anti–mouse IgG (Dynal). T cell
lines JR.2 and XV.1 were established from two separate donors
by culturing 1 3 106 freshly isolated g/d T cells in 1-ml culture
wells with 1 3 106 irradiated (5,000 rads) autologous CD11
monocyte-derived dendritic cells as APCs and the organic phase
of a chloroform/methanol/water (2:1:1) extract of M. tuberculosis
prepared as described (47) at 1:5,000 final dilution. After 2 wk of
culture, viable cells were recovered and the residual a/b T cells
were depleted with BMAO31 mAb and magnetic beads (Dynal).
The resulting population was restimulated with heterologous
CD11 dendritic cells, an organic phase extract of M. tuberculosis,
and rIL-2 (1 nM; Ajinomoto Co.). T cells were maintained by
restimulation every 2 wk with irradiated heterologous CD11
dendritic cells and rIL-2. T cell clones were derived from lines
JR.2 and XV.1 by limiting dilution culture using PHA stimula-
tion. T cells were seeded at 1 and 5 cells per well in 96-well
round-bottomed plates in a volume of 0.2 ml, with 5 3 104 irra-
diated (4,000 rads) heterologous PBMCs and 5 3 104 irradiated
(5,000 rads) EBV-transformed B lymphoblastoid cells as feeders
in RPMI medium supplemented with PHA-P (1:4,000 final di-
lution; Difco) and IL-2 (2 nM).
APC Lines. Monocyte-derived dendritic cells were gener-
ated from human blood monocytes that were isolated from the
byproducts of platelet pheresis and induced to differentiate and
express CD1a, CD1b, and CD1c by incubation with GM-CSF
1Abbreviations used in this paper: IPP, isopentenyl pyrophosphate; MEP,
monoethyl phosphate; UTR, untranslated region.939 Spada et al.
and IL-4 as described (48). The lymphoblastoid cell lines C1R
were transfected with the expression vector pSRa-Neo into
which cDNAs encoding either CD1a, CD1b, or CD1c were in-
serted as described previously (48). HeLa cells were either mock
transfected (HeLa Mock) or CD1c transfected (HeLa CD1c) (49).
Cytolytic Assays. Cytolytic assays were performed in a 4-h
chromium-release assay (43). The targets used were CD1-express-
ing GM-CSF/IL-4–treated blood monocytes; C1R lymphoblas-
toid cells either mock transfected (C1R Mock), CD1b transfected
(C1R CD1b), or CD1c transfected (C1R CD1c); and HeLa Mock
or HeLa CD1c cells (49). In the mAb blocking experiments, tar-
gets were incubated with mAbs (20 mg/ml) for 30 min at room
temperature before adding effector cells. In experiments where
both anti-Fas mAb and strontium ions were used, the targets
were incubated for 1 h with anti-Fas mAb (1 mg/ml) before add-
ing the effectors. The effector T cells were treated by incubating
with 25 mM strontium chloride hexahydrate (Aldrich Chemical
Co.) at 378C overnight, washing, and then counting after trypan
blue incubation to determine their viability. For the M. tuberculo-
sis–specific CD1b-restricted a/b T cell line DN1 (47), the target
C1R/CD1b was incubated overnight at 378C with M. tuberculosis
total sonicate at 1 mg/ml before T cell addition. For Vg2/Vd2 T
cell clones specific for IPP and related compounds, the antigen
monoethyl phosphate (MEP) was added together with the effec-
tors T cells and targets (1:300) (24). Assays were performed in
triplicate, and results were expressed as percent specific 51Cr re-
lease 6 SEM.
Proliferation Assays. 5 3 104 T cells were plated in triplicate in
96-well flat-bottomed plates with either 5 3 104 CD11 dendritic
cells or 5 3 104 mitomycin C–treated HeLa Mock and HeLa
CD1c cells as APCs. In the mAb blocking experiments, mAbs
were added as ascites (final dilution of 1:200) or purified mAbs
(20 mg/ml). Cultures were incubated at 378C, pulsed with 1 mCi
of [3H]thymidine (2 Ci/mmol; Amersham Pharmacia Biotech) on
day 2, and harvested 16 h later using a Tomtec harvester. The fil-
ter papers were counted on a Betaplate scintillation counter
(Wallac). Results were expressed as cpm 6 SEM.
Cytokine Assay. 5 3 105 T cells from the JR.2 and XV.1 lines
were cultured with 5 3 105 CD11 monocyte-derived dendritic
cells in the absence or presence of an anti-CD1c mAb (7C6) or
an IgM mAb control (NS4.1). PHA-P (1:4,000) was added as a
positive control. Supernatants were harvested after 24 and 48 h of
culture. Cytokine release was determined for IL-2, IL-4, IL-10,
and IFN-g by sandwich ELISA assay (50) using antibody pairs
purchased from PharMingen (IL-2, IL-4, IL-10) or from En-
dogen (IFN-g). Results were expressed as ng/ml 6 SEM.
Confocal Microscopy Analysis. For confocal microscopy analy-
sis, cells were fixed and permeabilized as described (49). For the
JR.2 line, cells were incubated with either antiperforin directly
conjugated with FITC (dG9 mAb, 1–4 ng/ml) or with antigran-
ulysin (DH2 mAb [51], 2.5–8 mg/ml) followed by incubation
with goat anti–mouse IgG-Cy3 (4 mg/ml; Jackson ImmunoRe-
search Labs), in single and double staining. Negative controls
were MPC11-FITC mAb (IgG2b isotype control for dG9 mAb)
together with DH2-Cy3, and P3-Cy3 mAb (IgG1 isotype control
for DH2 mAb) together with dG9-FITC. For the 12G12 clone,
cells were incubated either with dG9 mAb (3 mg/ml) or with
DH2 mAb followed by incubation with anti–mouse Ig–Texas red
(2.5–5  mg/ml; Molecular Probes) and goat anti–mouse IgG1-
FITC (2.5–5 mg/ml; Southern Biotechnology Associates), re-
spectively, in single and double staining. Controls were dG9–
Texas red with P3-FITC and DH2-FITC with MPC11–Texas
red, double staining. Each incubation was performed at 48C for 1 h;
in the double staining, cells were incubated for 10 min with 10%
mouse serum between the first and second mAb staining.
Immunoelectron Microscopy. For electron microscopy, T cells
were harvested from culture and dead cells were removed by Fi-
coll-Hypaque density gradient centrifugation. 0.5–1 3 107 live T
cells were fixed at room temperature with 2% glutaraldehyde
(Polysciences) in 0.1 M phosphate buffer for 2 h. The fixed cells
were then collected into 0.1 M phosphate buffer containing 0.2%
paraformaldehyde (Electron Microscopy Sciences) and processed
for ultrathin cryosectioning as described (52). Cryosections were
incubated with antigranulysin mAb, DH2, for 45 min, washed,
and then incubated with protein A–gold (Electron Microscopy
Laboratory, Utrecht University, Utrecht, The Netherlands) for
30 min. Labeled sections were viewed with a JOEL 1010 elec-
tron microscope at 80 kV.
TCR Analysis by PCR. Total RNA was isolated as described
(53) from six JR.2 clones obtained from the JR.2 line. The g and d
chains were amplified by PCR as described (29) using the following
primers: Vd1 chain, 59-GGGCTCGAGCTTCAGGCAGCA-
CAACT-39 (59 untranslated region [UTR]) and 59-GGGAGAT-
CTTGGCAGCTCTTTGATGGTGGTTGCTTTGGTTT-39 (Cd
region); Vg2 chain, 59-GGGGTCGACCTGGTGAAGTCATA-
CAGT-39 (Vg2 internal region) and 59-GGGXCTAGAGTGAG-
GTTCTCTGTGT-39 (Cg 39 UTR).
The PCR products were cloned into pBluescript II (Strat-
agene), and the sequences of the V-J junctional region were de-
termined using an automated sequencer (PE Applied Biosystems).
TCR Transfection. Full-length cDNAs encoding the JR.2 TCR
were amplified by PCR using the following primers: 59-GGGCT-
CGAGCTTCAGGCAGCACAACT-39 (Vd1 59 UTR), 59-GGG-
GGATCCGGAGTGTAGCTTCCTCAT-39 (Vd1 39 UTR),
59-GGGGGTACCTGCCCTGGCAGAAAGCA-39 (Vg2 59
UTR), and 59-GGGCTCGAGATGGCCTCCTTGTGC-39 (Vg2
39 UTR).
TCR reconstitution was carried out essentially as described
(54). The g and d cDNAs were cloned into pREP7 and pREP9
(Invitrogen), respectively. J.RT3-T3 cells, Jurkat derivatives that
lack cell surface TCR expression (55), were obtained from Ameri-
can Type Culture Collection. J.RT3-T3.5 cells were transfected
with 20 mg each of pREP7-JR.2g and pREP-JR.2d by elec-
troporation at 250 V, 960 mF with a Gene Pulser (Bio-Rad).
Control transfectants were electroporated with 20 mg each of the
pREP7 and pREP9 vectors alone. After 48 h, transfectants were
placed into medium containing 1 mg/ml geneticin (Life Tech-
nologies) and 0.5 mg/ml hygromycin B (Life Technologies). Af-
ter 2 wk, transfectants were analyzed for cell surface TCR expres-
sion by flow cytometry using anti-CD3 (SPV-T3b) and anti-Cd
TCR (anti–TCR-d1) mAbs and used as responders in T cell
stimulation assays. The JR.2/J.RT3 derived in this fashion had
35% TCR-g/d1 cells that stained with anti–TCR-d1 to a mean
fluorescence intensity of z100 on flow cytometry.
T Cell Transfectant Stimulation Assay. J.RT3-T3.5 transfectants
(1  3  105/well) were cultured in 96-well flat-bottomed microtiter
plates either in the presence of 10 ng/ml PMA alone, or in the
presence of PMA plus CD11 monocyte-derived dendritic cells
with or without the following mAbs (at a concentration of 20
mg/ml): P3 (isotype control), 10H3.9.3 (anti-CD1a), BCD1b3.2
(anti-CD1b), or F10/21A3.1 (anti-CD1c) in a total volume of
200 ml/well. 50 mg aliquots of the culture supernatants were col-
lected after 20–24 h culture at 378C and diluted 1:2 with culture
medium. To measure the amount of IL-2 released into the super-
natants, HT-2 cells (5,000/well) were added and cultured 25–30 h
at 378C. [3H]Thymidine (1 mCi/well, 6.7 Ci/mmol; New En-940 Human CD1c-reactive g/d T Lymphocytes
gland Nuclear) was added during the final 5–6 h of culture. Plates
were harvested on a Tomtec plate harvester, and [3H]thymidine
incorporation was measured in a Betaplate liquid scintillation
counter (Wallac).
Results
Derivation of CD1-reactive T Cell Lines. The limited germ-
line diversity of the g/d TCR had led to the suggestion that
these cells might recognize nonpolymorphic antigen-pre-
senting molecules (56). Since CD1 molecules resemble
MHC but lack polymorphism, we pursued efforts to isolate
CD1-restricted g/d T cells. To derive g/d T cell lines, nor-
mal human PBMCs were depleted of a/b T cells by anti-
body staining and magnetic bead separation. The g/d T
cell–enriched PBMCs were cultured in vitro with an or-
ganic phase extract of M. tuberculosis in the presence of CD1-
expressing monocyte-derived dendritic cells (see Materials
and Methods). After several restimulations and expansions,
two independently derived T cell lines, JR.2 and XV.1,
were obtained. Flow cytometric analyses revealed that both
lines were of the Vd1 g/d T cell subset. The JR.2 line ex-
pressed Vg2 (mAb TigA1) and Vd1/Jd1 (mAb dTCS11),
whereas the XV.1 line expressed Vg1.4 (mAb 4A111) and
Vd1/Jd1 (mAb dTCS11). Both cell lines lacked expression
of NKR-P1A, CD28, and CD4. As is common for g/d T
cells (57), 27% (JR.2) and 32% (XV.1) of the cells expressed
the CD8 a chain but not the CD8 b chain (Fig. 1, and data
not shown).
g/d T Cells Specifically Recognize CD1c1 APCs in Prolifer-
ation and Cytolytic Assays. Although the cell lines were
expanded in the presence of M. tuberculosis antigens, the T
cells did not specifically recognize M. tuberculosis antigens.
Instead, JR.2 cells proliferated in the presence of CD11
dendritic cells (64,675 cpm), even without M. tuberculosis
antigens. This response was not blocked by mAbs against
CD1a or CD1b, but was blocked to 307 cpm by mAb
against CD1c. Nearly identical results were obtained for
XV.1 cells (Fig. 2 A). Addition of a standard M. tuberculosis
lipid/lipoglycan extract (47) did not augment proliferation
by either line (data not shown). To confirm the specificity
suggested by mAb blocking, CD1c transfectant cells were
studied. JR.2 g/d T cells proliferated markedly to HeLa
CD1c (49) but not to HeLa Mock cells (Fig. 2 B). Note
that JR.2 T cells did not appear to recognize MICA, as
these T cells did not recognize the HeLa Mock cell line
that expresses MICA (58).
As it is known that many g/d cell lines are capable of
cell-mediated cytolysis (13), JR.2 and XV.1 T cells were
examined for their ability to lyse transfected C1R lympho-
blastoid cell lines C1R CD1b, C1R CD1c, or C1R Mock
(35). JR.2 and XV.1 T cells failed to lyse C1R CD1b or
C1R Mock targets, but efficiently lysed C1R CD1c targets
(70 and 62% specific lysis, respectively; Fig. 2 C). In each
case, lysis was specifically blocked (99 and 63% inhibition)
by anti-CD1c mAb. Similar results were obtained in cy-
tolytic assays using CD1-expressing monocyte-derived
Figure 1. Flow cytometric analysis
of JR.2 and XV.1 lines. The mAbs
used were P3 (IgG control), SPV-
T3b (anti-CD3), OKT4 (anti-CD4),
OKT8 (anti-CD8a), 9.3 (anti-
CD28), DX1 (anti–NKR-P1A),
anti–TCR-d1 (pan anti-Cd TCR),
dTCS1 (anti-Vd1/Jd1), TigA (anti-
Vg2), and 4A11 (anti-Vg1.4).
Figure 2. CD1c-specific recognition by JR.2 and XV.1 g/d T cell lines. (A) The proliferative response of JR.2 and XV.1 lines to CD1c1 dendritic cells
was inhibited by anti-CD1c mAb (F10/2A3) but not by anti–MHC class I, anti–MHC class II, anti-CD1a, and anti-CD1b mAbs. (B) The JR.2 T cell line
proliferated in response to HeLa CD1c cells but not to HeLa Mock cells. Background proliferation of HeLa Mock and HeLa CD1c cells alone was 872
and 1,197 cpm, respectively. (C) C1R Mock, C1R CD1b, and C1R CD1c targets were 51Cr labeled and tested in cytolytic assays with JR.2 and XV.1 T
cell lines at different E/T ratios (30:1 is shown) in the presence of anti-CD1b (BCD1b3.2) or anti-CD1c (F10/213) mAbs. Note that JR.2 and XV.1 lysed
only C1R CD1c transfectant cells and that lysis was blocked by anti-CD1c mAb. White bars, no mAb; black bars, anti-CD1b; gray bars, anti-CD1c.941 Spada et al.
dendritic cells (data not shown). Thus, JR.2 and XV.1 g/d
T cells were CD1c specific as revealed in the proliferation
and cytolytic analyses of CD1 transfectant cell lines and pro-
liferation assays with CD11 monocyte-derived dendritic cells.
Note that these experiments were performed without addi-
tion of M. tuberculosis antigens.
CD1c-reactive g/d T Cells Are Th1-like. To assess the abil-
ity to produce cytokines upon exposure to CD1c, cells
from the JR.2 line and the XV.1.14 clone were cocultured
with CD1-expressing human dendritic cells, and cytokine
levels were measured. Substantial levels of IFN-g (10 and
0.28 ng/ml, respectively) and IL-2 (19 and 17 ng/ml, re-
spectively) were produced after the T cell lines were ex-
posed to CD11 dendritic cells. Cytokines also were secreted
at somewhat higher levels after stimulation with the mito-
gen PHA (36 and 2.4 ng/ml IFN-g, and 45 and 9.2 ng/ml
IL-2, respectively). The production of these cytokines to
CD1c-expressing dendritic cells was blocked completely by
the presence of an anti-CD1c mAb (Fig. 3). In contrast to
these cytokines, IL-4 and IL-10 were undetectable under
these conditions (detection limits were ,16 pg/ml IL-4
and ,24 pg/ml IL-10 for cytokine ELISA). Thus, the pro-
file of cytokine production by CD1c-reactive g/d T cells
was Th1-like.
g/d T Cells Use Perforin-dependent and Fas-dependent Cyto-
toxicity Pathways. CD1-restricted, microbial-specific CD81
a/b T cells lyse targets using perforin-mediated pathways
and impart a bactericidal effect mediated by granulysin,
whereas CD1-restricted CD42CD82 a/b T cells lyse tar-
gets through Fas–FasL interaction (51, 59). As g/d T cells
typically display cytolytic potential, we examined the cellu-
lar cytotoxicity mechanisms that CD1c-reactive g/d T cells
used. Fas-dependent lysis can be inhibited by certain anti-
Fas mAbs, whereas exhaustive granule secretion induced by
strontium ions renders T cells dependent on perforin and
granule-related enzymes temporarily incapable of killing tar-
get cells (59). To determine the cellular cytotoxicity mech-
anism of g/d T cells, a panel of g/d T cells was examined
including the JR.2 line and IDP2 clone that are CD1c re-
active (60) and previously studied Vg2/Vd2-bearing clones,
12G12, DG.SF68, HD.108, and CP.1.15 (25, 57), that are
specific for small phosphate antigens such as MEP (24).
12G12 and CP.1.15 are CD81, whereas HD.108 and
DG.SF68 are CD42CD82. The antigen-specific lysis of
targets by all of these g/d T cell clones was consistently and
efficiently blocked by treatment with strontium ions (60–
84% average inhibition; Fig. 4). Inhibition was observed
when cells were treated with anti-Fas mAb as well, but this
inhibition was variable. In contrast to g/d T cells, the
TCR-a/b–expressing CD1b-restricted CD42CD82 T cell
line, DN1 (47), lysed antigen-pulsed targets in a manner
that was unaffected by pretreatment with strontium ions
but was efficiently blocked by mAb against Fas (Fig. 4).
These data indicate that cytolysis mediated by both Vd11
CD1c-reactive  g/d T cells and Vd21 prenyl pyrophos-
phate–specific g/d T cells can be both perforin mediated
and Fas mediated, like that described for CD81 MHC class
I–restricted a/b T cells (61).
g/d T Cells Express the Antimicrobial Protein, Granulysin.
Granulysin is a protein present in the cytotoxic granules of
cytolytic a/b T cells and NK cells (62) that has potent an-
timicrobial activity against a variety of bacteria including
M. tuberculosis, Staphylococcus aureus, and Listeria monocytoge-
nes (51). However, granulysin can kill intracellular bacteria
only after the infected cells are lysed by perforin (51). To
determine if CD1c-reactive g/d T cells express granulysin
and therefore had the potential to kill intracellular bacteria,
Figure 3. JR.2 and XV.1 g/d T cell lines show a Th1-like cytokines
profile. JR.2.1 and XV.1.14 clones were incubated with CD1c1 dendritic
cells for 24 and 48 h. The culture supernatants were collected and assayed
for IL-2, IFN-g, IL-4, and IL-10. Note that the JR.2.1 and XV.1.14
clones produced IFN-g and IL-2 in response to exposure to CD11 den-
dritic cells. IL-4 and IL-10 were not detected (data not shown).
Figure 4. Analysis of cytotoxicity mechanisms used by CD1c-reactive
and prenyl pyrophosphate–specific g/d T cells. CD1c-reactive Vg2/Vd1
T cells, JR.2 and IDP2, and prenyl pyrophosphate antigen–specific Vg2/
Vd2 T cell clones, 12G12, HD.108, CP.1.15, and DG.SF68, were used
in cytolytic assays performed in the presence or absence of anti-Fas mAb
to block Fas-mediated cytolysis or after treatment with strontium ions to
block perforin-mediated cytolysis. The mycolic acid–specific, CD1b-
restricted, CD42CD82 a/b T cell line, DN1, is shown as a control. MEP
is an alkyl phosphate analogue of the IPP antigen recognized by Vg2/Vd2
T cells and was used to stimulate the prenyl pyrophosphate–specific
clones. The E/T ratio was 10:1. Targets for CD1c-reactive and prenyl
pyrophosphate–specific g/d T cells were C1R CD1c cells. Targets for the
CD1b-restricted clone were C1R CD1b cells that had been incubated for
16 h at 378C with M. tuberculosis sonicate at 1 mg/ml. Note that the cy-
tolytic activity mediated by g/d T cells was blocked by both treatments
and thus depends on both granule secretion and Fas–FasL interactions.942 Human CD1c-reactive g/d T Lymphocytes
we examined the JR.2 cell line for expression of granulysin
and perforin. JR.2 (CD1c-reactive) as well as 12G12
(phosphoantigen-specific)  g/d T cell lines expressed both
granulysin and perforin. These proteins were found to
colocalize in cytolytic granules by confocal microscopy (Fig.
5 A). IgG control mAbs showed no significant staining re-
gardless of isotype (data not shown). Further studies by im-
munoelectron microscopy confirmed the presence of gran-
ulysin in the cytolytic granules of both the JR.2 line and
the 12G12 clone (Fig. 5 B) as demonstrated by the pres-
ence of immunogold particles in cytotoxic granules after
staining with an antigranulysin mAb.
TCR-g/d–mediated Recognition of CD1c. Although stud-
ies using mAb blocking and transfection of CD1c-encoding
expression vectors into recipient targets showed directly that
CD1c is the critical molecule recognized by Vd11 g/d T cells,
we sought to determine the role of the TCR in this recogni-
tion. To demonstrate that the TCR-g/d mediates recognition
of CD1c, a series of mAbs blocking experiments and TCR
transfection studies was carried out. mAbs against TCR-a/b
and TCR-g/d were tested for their ability to block JR.2 T
cell lysis of C1R CD1c transfectant cells. Only the mAb
against the TCR-g/d blocked killing (83% inhibition), sug-
gesting that CD1c recognition was TCR mediated (Fig. 6 A).
Figure 5. Expression of granulysin by g/d T cells. (A) Colocalization of granulysin
and perforin in the cytolytic granules. Differential interference contrast images of g/d T
cells are shown on the left. Confocal microscopic analysis of fluorescent immunostaining
of perforin and granulysin of the JR.2 CD1c-reactive g/d T cell line and 12G12 phos-
phoantigen–specific g/d T cell clone are shown as labeled. Superimposed figures are
showed in the right panels. Note that the counterstaining were exchanged such that per-
forin is green in the top panel but red in the bottom panel, and granulysin is red in the
top panel but green in the bottom panel. (B) Localization of granulysin to the cytotoxic
granules of g/d T cells by immunoelectron microscopy. The presence of granulysin in
the cytotoxic granules of JR.2 (bottom) and 12G12 (top) is demonstrated by the gold la-
beling (small particles) seen with antigranulysin mAb staining. c, centriole; e, endosome;
P, plasma membrane; m, mitochondria; n, nucleus; G, Golgi apparatus. Bar, 200 nm.943 Spada et al.
To formally demonstrate that the TCR plays a direct role in
the recognition of CD1c, we cloned the TCR g and d chains
from the CD1c-reactive JR.2 T cell clone by reverse tran-
scription PCR, transfected the JR.2 Vg2/Vd1 TCR into the
TCR-deficient recipient Jurkat T cell tumor cell line, and
measured the ability of the transfectants to produce IL-2 in re-
sponse to CD11 dendritic cells. When cultured with CD11
dendritic cells, the Vg2/Vd1 TCR transfectant (JR.2/J.RT3)
secreted IL-2 as judged in bioassays by the proliferation of
HT-2 cells (34,000 cpm; Fig. 6 B). The production of IL-2
was inhibited completely by adding anti-CD1c mAb, but not
anti-CD1a or anti-CD1b mAbs. Mock transfectant J.RT3 re-
cipient cells (Mock/J.RT3) did not produce IL-2 in response
to CD11 presenting cells. Thus, g/d T cell specificity for
CD1c is determined by the Vd1-containing TCR, as transfec-
tion of this TCR confers reactivity upon the recipient.
CD1c-reactive g/d T Cells Use Diverse TCRs. The rec-
ognition of CD1d antigen-presenting molecules by a/b T
cells in the absence of exogenous foreign antigens has been
observed for a unique subset of CD41 mouse NKT cells
expressing a canonical Va14-Ja281 rearrangement (63) as
well as for human T cells expressing the homologous
Va24-Ja18 rearrangement (50). The CD1c-reactive g/d T
cell lines derived here express g/d TCRs encoded by Vd1
gene segments (Fig. 1). To determine the nature of g/d
TCR diversity involved in recognition of CD1c, we am-
plified and sequenced the junctional regions of the g and d
chains of a JR.2 subclone. These sequences were compared
with those of g/d T cell line IDP2 (64, 65), previously
characterized as specific for CD1c (60). Both IDP2 and
JR.2 rearranged Vd1 to Dd2, Dd3, and Jd1 gene segments
to encode the junctional region of Vd1 chain. However
the amino acid sequences of the Vd1 chains in the CDR3
region of the two T cells have almost no homology and are
of substantially different lengths. The Vg2 chains of the
clones exhibited limited N region diversity but used differ-
ent Jg segments (Jg1.2 for JR.2 and Jg2.3 for IDP2; Fig. 7).
Vg usage differed in the XV.1 cell line that used the Vg1.4
gene segment and another CD1c-reactive Vd11 T cell
clone (66) that used either Vg1.3 or Vg1.4 with Jg2.3.
Thus, CD1c-reactive g/d T cells have divergent Vd1 junc-
tional regions rather than a canonical TCR as found on
CD1d-reactive NKT cells and can use different Vg gene
segments. However, since only a limited number of CD1c-
reactive TCRs has been analyzed, more TCRs will need to
be sequenced to determine the diversity of TCR junctions
used by CD1c-reactive g/d T cells.
Discussion
We have described and functionally analyzed g/d T cell
lines and clones derived from normal donors that directly
Figure 6. TCR-g/d mediates CD1c recognition. (A) JR.2.1 T cell
clone lysed C1R CD1c cells. Lysis was blocked by anti-CD1c mAb (F10/
2A3; not shown) as well by anti-Cd TCR mAb (anti–TCR-d1). E/T 30:1.
(B) JR.2 Vg2/Vd1 transfectant recognizes CD1c. The TCR2 J.RT3-T3
cell line was transfected with cDNAs encoding the Vg2/Vd1 TCR from
the JR.2 cell line or was mock transfected. The resulting JR.2/J.RT3 or
Mock/J.RT3 cell lines were cultured with CD11 dendritic cells in the
presence or absence of mAbs to CD1a, CD1b, and CD1c, and the super-
natants were harvested after 24 h. IL-2 release was assessed by the prolif-
eration of the IL-2–dependent HT-2 T cell line. Note that the JR.2/
J.RT3 but not the Mock/J.RT3 cell line released IL-2 when cultured
with CD11 monocyte-derived dendritic cells. This IL-2 release was com-
pletely blocked by the addition of an anti-CD1c mAb.
Figure 7. Diverse CDR3 junction region
of two CD1c-reactive Vg2/Vd1 T cell
clones, showing nucleotide sequence analy-
sis of the g and the d gene rearrangements of
JR.2 CD1c-reactive clone. Deduced amino
acid sequences are in the single letter code.
IDP2 sequence data are taken from Hata et
al. (reference 64) and Krangel et al. (refer-
ence 65) and are included for comparison.944 Human CD1c-reactive g/d T Lymphocytes
recognize human CD1c molecules. Compared with other
CD1-reactive T cells described in humans, these are re-
markable because their recognition was not dependent on
the presence of foreign lipid or glycolipid antigens. These
CD1c-reactive T cells constitute a subset of directly reactive
T cells that may be part of the innate immune system. A
certain similarity exists with murine CD41 a/b NKT cells
reactive to murine CD1.1, a homologue of human CD1d
(63, 67). These murine a/b T cells express markers of the NK
locus (NK1.1) and express nondiverse, canonical Va14-Ja281
TCR a chains frequently paired with diverse Vb8 chains.
The production of IL-4 and IFN-g by these NKT cells has
been implicated as an early immunoregulatory response in
mice (63, 68–70), and activation of these cells in vivo by
exogenous antigen directs conventional T cells to the Th2
phenotype (71, 72). The secretion of large amounts of IFN-g
in response to exogenous antigen can also inhibit ongoing
Th2 responses (69). In contrast, the g/d T cells described
here are reactive to CD1c, another CD1 family member.
Recognition of CD1c is through the g/d TCR as directly
demonstrated by transfection of the TCR (Fig. 6). TCR g
and d gene sequences from these T cells revealed the incor-
poration of template-independent N nucleotides resulting
in diverse noncanonical V-(D)-J junctions. Moreover,
CD1c-reactive  g/d T cells lacked expression of NKR-P1A
(Fig. 1), a human member of the family of NK receptors
analogous to murine NK1.1 (73).
It is not clear if the CD1c-reactive g/d T cells are re-
sponding to CD1c molecules alone or to CD1c molecules
containing a self-lipid molecule. The recent findings that in-
sect-derived murine CD1d molecules contain a bound lipid
in their antigen binding pocket (74), that mammalian CD1
can bind cellular glycosylphosphatidylinositol (75), and that
murine and human Va14 invariant chain, NKR1 a/b T
cells respond to autologous CD1d molecules loaded with
glycosylceramides (76, 77) suggest that the recognition of
murine CD1d involves CD1d-bound lipid. Thus, it seems
likely that the g/d T cells described here are recognizing a
self-lipid presented by CD1c. However, such a lipid must be
broadly distributed, being present in B cells, HeLa cells, and
dendritic cells, as CD1c expressed on these various cell
sources was recognized in each case (Fig. 2, A and B).
The recognition of CD1c by human g/d T cells may be
an important form of antigen recognition by these T cells.
Recognition of CD1c by g/d T cells in the absence of exog-
enous foreign antigens could be compared with the alloreac-
tive and autoreactive recognition of MHC class I and class II
proteins by a/b T cells that are easily detected in MLRs
(mixed lymphocyte reactions) and AMLRs (autologous
mixed lymphocyte reactions) (78). Thus, autoreactivity to
restricting elements may be a common theme between
TCRs that recognize foreign antigens in the context of MHC
or CD1.
The best-studied human g/d T cell reactivity is to small
aliphatic phosphate molecules typically composed of an iso-
prenoid chain linked to a pyrophosphate moiety (24). Re-
cently, we have characterized another class of aliphatic mol-
ecules typically consisting of four or five carbons chains
linked to a primary amine (26). Recognition of these small
aliphatic compounds may represent a form of pattern recog-
nition by the major circulating g/d T cell subset defined by
expression of Vd2 TCR. The Vg2/Vd2 subset of g/d T cells
accounts for the vast majority of human g/d T cells in the
circulation.
Here, we characterized recognition by the Vd1 subset of
g/d T cells, the major population in tissues such as the in-
testine and the spleen. We suggest that this subset of g/d T
cells focuses on recognition of nonpolymorphic cell surface
molecules related in structure to classical MHC molecules.
Groh and Spies have recently demonstrated that some mem-
bers of this g/d T cell subset killed target cells expressing
stress-induced MICA and MICB MHC–encoded struc-
tures (32) through reactivity with the NKG2D NK recep-
tor (33). Although mAbs specific for the g/d TCR blocked
g/d T cell killing of MICA1 targets (32), the blocking was
partial and TCR gene transfer was not done. It remains to
be definitely determined if Vd11 TCRs can recognize MICA.
Here, we show that some members of this same receptor
subset recognize nonpolymorphic CD1c. Two other de-
scribed g/d T cell clones reactive with human CD1c also
expressed TCRs encoded by the Vd1 gene segment (60,
66). Moreover, we have derived and partially characterized
two additional Vd11 T cell lines that recognize CD1c (data
not shown). Thus, these findings suggest that CD1c reactiv-
ity may be common among Vd11 T cells. However, it is
clear that many Vd11 T cells are not CD1c reactive (data not
shown), and further studies will be needed to determine the
frequency of CD1c-reactive g/d T cells. Additionally, since
the above g/d T cell lines were derived by in vitro culture,
primary resident CD1c-reactive g/d T cells in situ may not
be able to respond to CD1c due to anergy.
Direct recognition of CD1c by Vd11 T cells may repre-
sent a bridge between innate and adaptive immunity in a
similar fashion to recognition of CD1d by murine and hu-
man NK1 a/b T cells (50, 63). Such CD1d-reactive a/b
T cells are critically required to mediate IL-12–induced tu-
mor immunity in mice (68), can polarize other T cells to a
Th2 phenotype when activated by exogenous antigen (71,
72), and play regulatory roles in listerial infection (79) and
Th2 responses (69). We speculate that CD1c-reactive g/d
T cells also have unique immunological functions. Evidence
from in vivo and in vitro experiments has demonstrated
that g/d T cells play roles complementary to those of con-
ventional a/b T cells in the host defense against infectious
agents, in autoimmune diseases, and in tumor surveillance.
We demonstrate here that both the CD1c- and the phosphate
antigen–reactive g/d T cells are cytotoxic and can use the
perforin-dependent cytotoxicity pathway. The perforin
pathway plays an important role in antiviral immunity, re-
sistance to intracellular bacteria, tumor surveillance, and
other immune functions because it is the primary cyto-
toxic effector mechanism in host defense (61). Further un-
derscoring the potential functional importance of g/d T
cells in vivo, we show for the first time that g/d T cells
express granulysin, a potent antimicrobial protein that in
conjunction with perforin kills intracellular M. tuberculosis945 Spada et al.
organisms (51). Granulysin also kills a wide variety of mi-
crobes in vitro (51, 62). Moreover, the CD1c-reactive g/d
T cells possess a Th1-like cytokine profile, producing sig-
nificant amount of IFN-g and IL-2.
CD1 molecules can be directly induced on monocytes as
they differentiate into dendritic cells in response to GM-CSF
or indirectly in response to agents such as bacteria or inflam-
matory products that induce the secretion of GM-CSF. Such
de novo expression of CD1c can be seen on dendritic cells in
granulomas induced by Mycobacterium leprae infection in lep-
rosy (80). We speculate that this new expression of CD1c, or
stress-induced endogenous lipid antigens presented by
CD1c, could then activate tissue Vd11 T cells that are spe-
cific for CD1c. After their activation, the CD1c-reactive g/d
T cells could play a role in directing conventional a/b T
cells to the acquisition of a Th1 phenotype through their se-
cretion of IFN-g. The early secretion of cytokines by mu-
rine g/d T cells during responses to infectious agents pro-
vides evidence for such a role (81). These cells, then, could
serve an analogous functional role to that proposed for
Va141NK1.11 T cells, except CD1c recognition by g/d T
cells would lead to IFN-g production rather than to IFN-g
and IL-4 production that is seen with most NK1.11 T cells.
As CD1c-specific g/d T cells are cytotoxic and express gran-
ulysin, they could also lyse infected dendritic cells via the
perforin pathway and kill released intracellular bacteria by se-
cretion of granulysin. In addition, as CD1c is expressed on
some circulating B cells and on mantle zone B cells in lymph
nodes (although at low levels) (82–84), Vd11 g/d T cells
may play a role in T cell–B cell interactions.
Since various professional APCs, including B cells, tis-
sue dendritic cells, activated monocytes, and activated
macrophages in humans all express CD1c and since g/d T
cells recognizing CD1c appear to do so in the absence of
foreign antigens before foreign antigen–specific T cells dif-
ferentiate and expand, upregulation of CD1c could repre-
sent an innate danger signal through the activation of
CD1c-specific g/d T cells. Thus, such g/d T cells may
play an early role by activating APCs via Th1 cytokines or
may play a role in host defense by directly killing microbes
via the combination of perforin and granulysin.
We thank Jack F. Bukowski for helpful suggestions.
This work was supported by the National Institutes of Health
(M.B. Brenner, S.A. Porcelli, A.M. Krensky, and C.T. Morita), the
Arthritis Foundation (S.A. Porcelli and C.T. Morita), and the
American College of Rheumatology (C.T. Morita). A.M. Krensky
is a Burroughs Wellcome Scholar in Experimental Therapeutics
and the Shelagh Galligan Professor of Pediatrics.
Submitted: 15 September 1999
Revised: 10 November 1999
Accepted: 17 November 1999
Released online: 13 March 2000
References
1. Hiromatsu, K., Y. Yoshikai, G. Matsuzaki, S. Ohga, K. Mu-
ramori, K. Matsumoto, J.A. Bluestone, and K. Nomoto.
1992. A protective role of g/d T cells in primary infection
with Listeria monocytogenes in mice. J. Exp. Med. 175:49–56.
2. Ladel, C.H., C. Blum, A. Dreher, K. Reifenberg, and S.H.E.
Kaufmann. 1995. Protective role of g/d T cells and a/b T
cells in tuberculosis. Eur. J. Immunol. 25:2877–2881.
3. Ladel, C.H., J. Hess, S. Daugelat, P. Mombaerts, S. Tone-
gawa, and S.H.E. Kaufmann. 1995. Contribution of a/b and
g/d T lymphocytes to immunity against Mycobacterium bovis
bacillus Calmette Guérin: studies with T cell receptor-defi-
cient mutant mice. Eur. J. Immunol. 25:838–846.
4. D’Souza, C.D., A.M. Cooper, A.A. Frank, R.J. Mazzaccaro,
B.R. Bloom, and I.M. Orme. 1997. An anti-inflammatory
role for gd T lymphocytes in acquired immunity to Mycobac-
terium tuberculosis. J. Immunol. 158:1217–1221.
5. Tsuji, M., P. Mombaerts, L. Lefrancois, R.S. Nussenzweig,
F. Zavala, and S. Tonegawa. 1994. gd T cells contribute to
immunity against the liver stages of malaria in ab T-cell-
deficient mice. Proc. Natl. Acad. Sci. USA. 91:345–349.
6. Sciammas, R., P. Kodukula, Q. Tang, R.L. Hendricks, and
J.A. Bluestone. 1997. T cell receptor-g/d cells protect mice
from herpes simplex virus type 1–induced lethal encephalitis.
J. Exp. Med. 185:1969–1975.
7. King, D.P., D.M. Hyde, K.A. Jackson, D.M. Novosad, T.N.
Ellis, L. Putney, M.Y. Stovall, L.S. Van Winkle, B.L. Bea-
man, and D.A. Ferrick. 1999. Protective response to pulmo-
nary injury requires gd T lymphocytes. J. Immunol. 162:
5033–5036.
8. Jouen-Beades, F., E. Paris, C. Dieulois, J.-F. Lemeland, V.
Barre-Dezelus, S. Marret, G. Humbert, J. Leroy, and F.
Tron. 1997. In vivo and in vitro activation and expansion of
gd T cells during Listeria monocytogenes infection in humans.
Infect. Immun. 65:4267–4272.
9. Balbi, B., M.T. Valle, S. Oddera, D. Giunti, F. Manca, G.A.
Rossi, and L. Allegra. 1993. T-lymphocytes with gd1 Vd21
antigen receptors are present in increased proportions in a
fraction of patients with tuberculosis or with sarcoidosis. Am.
Rev. Respir. Dis. 148:1685–1690.
10. Bertotto, A., R. Gerli, F. Spinozzi, C. Muscat, F. Scalise, G.
Castellucci, M. Sposito, F. Candio, and R. Vaccaro. 1993.
Lymphocytes bearing the gd T cell receptor in acute Brucella
melitensis infection. Eur. J. Immunol. 23:1177–1180.
11. Caldwell, C.W., E.D. Everett, G. McDonald, Y.W. Yesus,
and W.E. Roland. 1995. Lymphocytosis of g/d T cells in
human ehrlichiosis. Am. J. Clin. Pathol. 103:761–766.
12. Haas, W., P. Pereira, and S. Tonegawa. 1993. Gamma/delta
cells. Annu. Rev. Immunol. 11:637–685.
13. Porcelli, S., M.B. Brenner, and H. Band. 1991. Biology of
the human gd T-cell receptor. Immunol. Rev. 120:137–183.
14. Johnson, R.M., D.W. Lancki, A.I. Sperling, R.F. Dick, P.G.
Spear, F.W. Fitch, and J.A. Bluestone. 1992. A murine CD42,
CD82 T cell receptor-gd T lymphocyte clone specific for her-
pes simplex virus glycoprotein I. J. Immunol. 148:983–988.
15. Schild, H., N. Mavaddat, C. Litzenberger, E.W. Ehrich,
M.M. Davis, J.A. Bluestone, L. Matis, R.K. Draper, and
Y.-h. Chien. 1994. The nature of major histocompatibility
complex recognition by gd T cells. Cell. 76:29–37.
16. Crowley, M.P., Z. Reich, N. Mavaddat, J.D. Altman, and
Y.-h. Chien. 1997. The recognition of the nonclassical major
histocompatibility complex (MHC) class I molecule, T10, by
the gd T cell, G8. J. Exp. Med. 185:1223–1230.
17. Rock, E.P., P.R. Sibbald, M.M. Davis, and Y.-h. Chien.
1994. CDR3 length in antigen-specific immune receptors. J.
Exp. Med. 179:323–328.946 Human CD1c-reactive g/d T Lymphocytes
18. Li, H., M.I. Lebedeva, A.S. Llera, B.A. Fields, M.B. Brenner,
and R.A. Mariuzza. 1998. Structure of the Vd domain of a
human gd T-cell antigen receptor. Nature. 391:502–506.
19. Morita, C.T., H.K. Lee, D.S. Leslie, Y.T. Tanaka, J.F.
Bukowski, and E. Märker-Hermann. 1999. Recognition of
nonpeptide prenyl pyrophosphate antigens by human gd T
cells. Microbes Infect. 1:175–186.
20. Kabelitz, D., A. Bender, S. Schondelmaier, B. Schoel, and
S.H.E. Kaufmann. 1990. A large fraction of human peripheral
blood g/d1 T cells is activated by Mycobacterium tuberculosis but
not by its 65-kD heat shock protein. J. Exp. Med. 171:667–679.
21. Pfeffer, K., B. Schoel, H. Gulle, S.H.E. Kaufmann, and H.
Wagner. 1990. Primary responses of human T cells to myco-
bacteria: a frequent set of g/d T cells are stimulated by pro-
tease-resistant ligands. Eur. J. Immunol. 20:1175–1179.
22. Panchamoorthy, G., J. McLean, R.L. Modlin, C.T. Morita,
S. Ishikawa, M.B. Brenner, and H. Band. 1991. A predomi-
nance of the T cell receptor Vg2/Vd2 subset in human my-
cobacteria-responsive T cells suggests germline gene encoded
recognition. J. Immunol. 147:3360–3369.
23. Morita, C.T., E.M. Beckman, J.F. Bukowski, Y. Tanaka, H.
Band, B.R. Bloom, D.E. Golan, and M.B. Brenner. 1995.
Direct presentation of nonpeptide prenyl pyrophosphate anti-
gens to human gd T cells. Immunity. 3:495–507.
24. Tanaka, Y., C.T. Morita, Y. Tanaka, E. Nieves, M.B. Brenner,
and B.R. Bloom. 1995. Natural and synthetic non-peptide an-
tigens recognized by human gd T cells. Nature. 375:155–158.
25. Tanaka, Y., S. Sano, E. Nieves, G. De Libero, D. Roca, R.L.
Modlin, M.B. Brenner, B.R. Bloom, and C.T. Morita. 1994.
Nonpeptide ligands for human gd T cells. Proc. Natl. Acad.
Sci. USA. 91:8175–8179.
26. Bukowski, J.F., C.T. Morita, and M.B. Brenner. 1999. Hu-
man gd T cells recognize alkylamines derived from microbes,
edible plants, and tea: implications for innate immunity. Im-
munity. 11:57–65.
27. Lang, F., M.A. Peyrat, P. Constant, F. Davodeau, J. David-
Ameline, Y. Poquet, H. Vié, J.J. Fournié, and M. Bonneville.
1995. Early activation of human Vg9Vd2 T cell broad cyto-
toxicity and TNF production by nonpeptidic mycobacterial
ligands. J. Immunol. 154:5986–5994.
28. Holoshitz, J., N.C. Romzek, Y. Jia, L. Wagner, L.M. Vila,
S.-J. Chen, J.M. Wilson, and D.R. Karp. 1993. MHC-inde-
pendent presentation of mycobacteria to human gd T cells.
Int. Immunol. 5:1437–1443.
29. Bukowski, J.F., C.T. Morita, Y. Tanaka, B.R. Bloom, M.B.
Brenner, and H. Band. 1995. Vg2Vd2 TCR-dependent rec-
ognition of non-peptide antigens and Daudi cells analyzed by
TCR gene transfer. J. Immunol. 154:998–1006.
30. Bukowski, J.F., C.T. Morita, H. Band, and M.B. Brenner.
1998. Crucial role of TCRg chain junctional region in pre-
nyl pyrophosphate antigen recognition by gd T cells. J. Im-
munol. 161:286–293.
31. Falini, B., L. Flenghi, S. Pileri, P. Pelicci, M. Fagioli, M.F. Mar-
telli, L. Moretta, and E. Ciccone. 1989. Distribution of T cells
bearing different forms of the T cell receptor g/d in normal and
pathological human tissues. J. Immunol. 143:2480–2488.
32. Groh, V., A. Steinle, S. Bauer, and T. Spies. 1998. Recogni-
tion of stress-induced MHC molecules by intestinal epithelial
gd T cells. Science. 279:1737–1740.
33. Bauer, S., V. Groh, J. Wu, A. Steinle, J.H. Phillips, L.L.
Lanier, and T. Spies. 1999. Activation of NK cells and T cells
by NKG2D, a receptor for stress-inducible MICA. Science.
285:727–729.
34. Li, P., S.T. Willie, S. Bauer, D.L. Morris, T. Spies, and R.K.
Strong. 1999. Crystal structure of the MHC class I homolog
MIC-A, a gd T cell ligand. Immunity. 10:577–584.
35. Beckman, E.M., A. Melian, S.M. Behar, P.A. Sieling, D.
Chatterjee, S.T. Furlong, R. Matsumoto, J.P. Rosat, R.L.
Modlin, and S.A. Porcelli. 1996. CD1c restricts responses of
mycobacteria-specific T cells. Evidence for antigen presenta-
tion by a second member of the human CD1 family. J. Immu-
nol. 157:2795–2803.
36. Spits, H., G. Keizer, J. Borst, C. Terhorst, A. Hekman, and
J.E. de Vries. 1983. Characterization of monoclonal antibod-
ies against cell surface molecules associated with cytotoxic ac-
tivity of natural and activated killer cells and cloned CTL
lines. Hybridoma. 2:423–437.
37. Band, H., F. Hochstenbach, J. McLean, S. Hata, M.S. Kran-
gel, and M.B. Brenner. 1987. Immunochemical proof that a
novel rearranging gene encodes the T cell receptor d subunit.
Science. 238:682–684.
38. Wu, Y.J., W.T. Tian, R.M. Snider, C. Rittershaus, P. Rog-
ers, L. LaManna, and S.H. Ip. 1988. Signal transduction of g/d
T cell antigen receptor with a novel mitogenic anti-d anti-
body. J. Immunol. 141:1476–1479.
39. Jitsukawa, S., F. Faure, M. Lipinski, F. Triebel, and T. Her-
cend. 1987. A novel subset of human lymphocytes with a T
cell receptor-g complex. J. Exp. Med. 166:1192–1197.
40. Band, H., F. Hochstenbach, C.M. Parker, J. McLean, M.S.
Krangel, and M.B. Brenner. 1989. Expression of human T cell
receptor-gd structural forms. J. Immunol. 142:3627–3633.
41. Linsley, P.S., J.L. Greene, P. Tan, J. Bradshaw, J.R. Ledbet-
ter, C. Anasetti, and N.K. Damle. 1992. Coexpression and
functional cooperation of CTLA-4 and CD28 on activated T
lymphocytes. J. Exp. Med. 176:1595–1604.
42. Martin, L.H., F. Calabi, F.A. Lefebvre, C.A. Bilsland, and C.
Milstein. 1987. Structure and expression of the human thy-
mocyte antigens CD1a, CD1b, and CD1c. Proc. Natl. Acad.
Sci. USA. 84:9189–9193.
42a.Grant, E.P., M. Degano, J.P. Rosat, S. Stenger, R.L. Mod-
lin, I.A. Wilson, S.A. Porcelli, and M.B. Brenner. 1999. Mo-
lecular recognition of lipid antigens by T cell receptors. J.
Exp. Med. 189:195–205.
43. Behar, S.M., S.A. Porcelli, E.M. Beckman, and M.B. Bren-
ner. 1995. A pathway of costimulation that prevents anergy
in CD282 T cells: B7-independent costimulation of CD1-re-
stricted T cells. J. Exp. Med. 182:2007–2018.
44. Olive, D., P. Dubreuil, and C. Mawas. 1984. Two distinct
TL-like molecular subsets defined by monoclonal antibodies
on the surface of human thymocytes with different expression
on leukemia lines. Immunogenetics. 20:253–264.
45. De Libero, G., G. Casorati, C. Giachino, C. Carbonara, N.
Migone, P. Matzinger, and A. Lanzavecchia. 1991. Selection
by two powerful antigens may account for the presence of
the major population of human peripheral g/d T cells. J.
Exp. Med. 173:1311–1322.
46. Hanson, D.A., A. Kasper, F.R. Poulain, and A.M. Krensky.
1999. Biosynthesis of granulysin, a novel cytolytic molecule.
Mol. Immunol. 36:413–422.
47. Beckman, E.M., S.A. Porcelli, C.T. Morita, S.M. Behar,
S.T. Furlong, and M.B. Brenner. 1994. Recognition of a
lipid antigen by CD1-restricted ab1 T cells. Nature. 372:
691–694.
48. Porcelli, S., C.T. Morita, and M.B. Brenner. 1992. CD1b re-
stricts the response of human CD4282 T lymphocytes to a
microbial antigen. Nature. 360:593–597.947 Spada et al.
49. Sugita, M., R.M. Jackman, E. van Donselaar, S.M. Behar,
R.A. Rogers, P.J. Peters, M.B. Brenner, and S.A. Porcelli.
1996. Cytoplasmic tail-dependent localization of CD1b anti-
gen-presenting molecules to MIICs. Science. 273:349–352.
50. Exley, M., J. Garcia, S.P. Balk, and S. Porcelli. 1997. Re-
quirements for CD1d recognition by human invariant
Va241 CD42CD82 T cells. J. Exp. Med. 186:109–120.
51. Stenger, S., D.A. Hanson, R. Teitelbaum, P. Dewan, K.R.
Niazi, C.J. Froelich, T. Ganz, S. Thoma-Uszynski, A. Me-
lian, C. Bogdan, et al. 1998. An antimicrobial activity of cy-
tolytic T cells mediated by granulysin. Science. 282:121–125.
52. Peters, P.J., J.J. Neefjes, V. Oorschot, H.L. Ploegh, and H.J.
Geuze. 1991. Segregation of MHC class II molecules from
MHC class I molecules in the Golgi complex for transport to
lysosomal compartments. Nature. 349:669–676.
53. Chomczynski, P., and N. Sacchi. 1987. Single-step method
of RNA isolation by acid guanidinium thiocyanate-phenol-
chloroform extraction. Anal. Biochem. 162:156–159.
54. Brawley, J.V., and P. Concannon. 1996. Modulation of pro-
miscuous T cell receptor recognition by mutagenesis of
CDR2 residues. J. Exp. Med. 183:2043–2051.
55. Weiss, A., and J.D. Stobo. 1984. Requirement for the coex-
pression of T3 and the T cell antigen receptor on a malignant
human T cell line. J. Exp. Med. 160:1284–1299.
56. Brenner, M.B., J.L. Strominger, and M.S. Krangel. 1988.
The  gd T cell receptor. Adv. Immunol. 43:133–192.
57. Morita, C.T., S. Verma, P. Aparicio, C. Martinez-A, H.
Spits, and M.B. Brenner. 1991. Functionally distinct subsets
of human g/d T cells. Eur. J. Immunol. 21:2999–3007.
58. Zwirner, N.W., M.A. Fernández-Viña, and P. Stastny. 1998.
MICA, a new polymorphic HLA-related antigen, is ex-
pressed mainly by keratinocytes, endothelial cells, and mono-
cytes. Immunogenetics. 47:139–148.
59. Stenger, S., R.J. Mazzaccaro, K. Uyemura, S. Cho, P.F.
Barnes, J.P. Rosat, A. Sette, M.B. Brenner, S.A. Porcelli,
B.R. Bloom, and R.L. Modlin. 1997. Differential effects of
cytolytic T cell subsets on intracellular infection. Science. 276:
1684–1687.
60. Porcelli, S., M.B. Brenner, J.L. Greenstein, S.P. Balk, C.
Terhorst, and P.A. Bleicher. 1989. Recognition of cluster of
differentiation 1 antigens by human CD42CD82 cytolytic T
lymphocytes. Nature. 341:447–450.
61. Kagi, D., B. Ledermann, K. Burki, R.M. Zinkernagel, and
H. Hengartner. 1996. Molecular mechanisms of lymphocyte-
mediated cytotoxicity and their role in immunological pro-
tection and pathogenesis in vivo. Annu. Rev. Immunol. 14:
207–232.
62. Pena, S.V., D.A. Hanson, B.A. Carr, T.J. Goralski, and A.M.
Krensky. 1997. Processing, subcellular localization, and func-
tion of 519 (granulysin), a human late T cell activation mole-
cule with homology to small, lytic, granule proteins. J. Immu-
nol. 158:2680–2688.
63. Bendelac, A., M.N. Rivera, S.H. Park, and J.H. Roark.
1997. Mouse CD1-specific NK1 T cells: development, spec-
ificity, and function. Annu. Rev. Immunol. 15:535–562.
64. Hata, S., M. Brenner, and M. Krangel. 1987. Identification of
putative human T cell receptor d complementary DNA
clones.  Science. 238:678–682.
65. Krangel, M., H. Band, S. Hata, J. McLean, and M. Brenner.
1987. Structurally divergent human T cell receptor proteins
encoded by distinct Cg genes. Science. 237:64–67.
66. Faure, F., S. Jitsukawa, C. Miossec, and T. Hercend. 1990.
CD1c as a target recognition structure for human T lympho-
cytes: analysis with peripheral blood g/d cells. Eur. J. Immu-
nol. 20:703–706.
67. Porcelli, S.A. 1995. The CD1 family: a third lineage of anti-
gen-presenting molecules. Adv. Immunol. 59:1–98.
68. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y.
Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997.
Requirement for Va14 NKT cells in IL-12-mediated rejec-
tion of tumors. Science. 278:1623–1626.
69. Cui, J., N. Watanabe, T. Kawano, M. Yamashita, T. Kamata,
C. Shimizu, M. Kimura, E. Shimizu, J. Koike, H. Koseki, et
al. 1999. Inhibition of T helper cell type 2 cell differentiation
and immunoglobulin E response by ligand-activated Va14
natural killer T cells. J. Exp. Med. 190:783–792.
70. Carnaud, C., D. Lee, O. Donnars, S.H. Park, A. Beavis, Y.
Koezuka, and A. Bendelac. 1999. Cross-talk between cells of
the innate immune system: NKT cells rapidly activate NK
cells. J. Immunol. 163:4647–4650.
71. Burdin, N., L. Brossay, and M. Kronenberg. 1999. Immuni-
zation with a-galactosylceramide polarizes CD1-reactive NK
T cells towards Th2 cytokine synthesis. Eur. J. Immunol. 29:
2014–2025.
72. Singh, N., S. Hong, D.C. Scherer, I. Serizawa, N. Burdin,
M. Kronenberg, Y. Koezuka, and L. Van Kaer. 1999. Acti-
vation of NK T cells by CD1d and a-galactosylceramide di-
rects conventional T cells to the acquisition of a Th2 pheno-
type. J. Immunol. 163:2373–2377.
73. Lanier, L.L., C. Chang, and J.H. Phillips. 1994. Human
NKR-P1A. A disulfide-linked homodimer of the C-type
lectin superfamily expressed by a subset of NK and T lym-
phocytes. J. Immunol. 153:2417–2428.
74. Zeng, Z.-H., A.R. Castaño, B.W. Segelke, E.A. Stura, P.A.
Peterson, and I.A. Wilson. 1997. Crystal structure of mouse
CD1: an MHC-like fold with a large hydrophobic binding
groove. Science. 277:339–345.
75. Joyce, S., A.S. Woods, J.W. Yewdell, J.R. Bennink, A.D. De
Silva, A. Boesteanu, S.P. Balk, R.J. Cotter, and R.R. Brut-
kiewicz. 1998. Natural ligand of mouse CD1d1: cellular gly-
cosylphosphatidylinositol. Science. 279:1541–1544.
76. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K.
Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al.
1997. CD1d-restricted and TCR-mediated activation of
Va14 NKT cells by glycosylceramides. Science. 278:1626–
1629.
77. Spada, F.M., Y. Koezuka, and S.A. Porcelli. 1998. CD1d-
restricted recognition of synthetic glycolipid antigens by hu-
man natural killer T cells. J. Exp. Med. 188:1529–1534.
78. Sherman, L.A., and S. Chattopadhyay. 1993. The molecular
basis of allorecognition. Annu. Rev. Immunol. 11:385–402.
79. Szalay, G., C.H. Ladel, C. Blum, L. Brossay, M. Kronenberg,
and S.H. Kaufmann. 1999. Anti-CD1 monoclonal antibody
treatment reverses the production patterns of TGF-b2 and
Th1 cytokines and ameliorates listeriosis in mice. J. Immunol.
162:6955–6958.
80. Sieling, P.A., D. Jullien, M. Dahlem, T.F. Tedder, T.H.
Rea, R.L. Modlin, and S.A. Porcelli. 1999. CD1 expression
by dendritic cells in human leprosy lesions: correlation with
effective host immunity. J. Immunol. 162:1851–1858.
81. Ferrick, D.A., M.D. Schrenzel, T. Mulvania, B. Hsieh, W.G.
Ferlin, and H. Lepper. 1995. Differential production of inter-
feron-g and interleukin-4 in response to Th1- and Th2-stim-
ulating pathogens by gd T cells in vivo. Nature. 373:255–257.
82. Small, T.N., R.W. Knowles, C. Keever, N.A. Kernan, N.
Collins, R.J. O’Reilly, B. Dupont, and N. Flomenberg.948 Human CD1c-reactive g/d T Lymphocytes
1987. M241 (CD1) expression on B lymphocytes. J. Immu-
nol. 138:2864–2868.
83. Small, T.N., C. Keever, N. Collins, B. Dupont, R.J.
O’Reilly, and N. Flomenberg. 1989. Characterization of B
cells in severe combined immunodeficiency disease. Hum.
Immunol. 25:181–193.
84. Cattoretti, G., E. Berti, C. Parravicini, M. Buscaglia, F. Cap-
pio, R. Caputo, A. Cerri, L. Crosti, D. Delia, G. Gaiera, and
N. Polli. 1989. Expression of CD1 molecules on dendritic
cells: ontogeny, epitope analysis on normal and malignant
cells, and tissue distribution. In Leukocyte Typing IV. W.
Knapp, B. Dorken, W.R. Gilks, E.P. Rieber, R.E. Schmidt,
H. Stein, and A.E.G.K. von dem Borne, editors. Oxford
University Press, Oxford. 263–264.